GlassScriptPhysician profile
Melhem A Imad
NPI 1417908138
$6,724.51
in general payments reported to CMS, 2019-2025
40 companies · $1,308 in 2025
The $1,308 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,753 · 2020: $393 · 2021: $1,104 · 2022: $1,737 · 2023: $193 · 2024: $237 · 2025: $1,308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $889 · Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $888.85 |
| Food and Beverage | $849.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,455.93 | 2022-2025 | |
| Pulmonx Corporation | $1,243.16 | 2019-2025 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
| Glaxosmithkline, LLC. | $555.07 | 2019-2024 | Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $406.71 | 2019-2024 | Airsupra |
| Grifols USA, LLC | $291.05 | 2020-2025 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $285.65 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $251.90 | 2019-2022 | |
| Abbvie INC. | $165.47 | 2021-2024 | |
| Sunovion Pharmaceuticals INC. | $161.36 | 2019-2021 | |
| Galvanize Therapeutics, INC | $157.06 | 2025 | Aliya System |
| Abiomed | $128.04 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $117.89 | 2019-2022 | |
| Medtronic, INC. | $111.05 | 2021-2025 | Interstim |
| Advanced Respiratory, INC | $110.59 | 2019-2021 | |
| Livanova USA, INC. | $109.84 | 2023 | Lifesparc |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melhem Imad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.